Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT06735625 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Pilot Study "AHSP as a Biomarker of Sickle Cell Disease in a Population of Adults and Children"

Study acronym: AHSPDREP
StatusRecruiting
PhaseNot applicable
Started
View on ClinicalTrials.gov ↗
Record status
This record was last updated April 2, 2025 (before its estimated March 20, 2026 completion). Its status may not reflect the trial's current state.

Record History

See every version on ClinicalTrials.gov ↗

  1. Trial status: Not Yet Recruiting to Recruiting
    • Study sites: 0 to 1
    • Start date changed from estimate of Jan 20, 2025 to Mar 6, 2025
    v3
  2. Interventions: Research sampling (Biological) to Measurement of AHSP concentration (Biological)
    • Collaborators expanded, about 2 words
    v2
  3. Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
Evaluation of AHSP concentration in total blood as a biomarker in adult and pediatric sickle cell patients
Trial Details
NCT Number NCT06735625
Lead Sponsor Centre Hospitalier de Saint-Denis
Collaborators: Inserm U955
Conditions
(from sponsor)		 in Relation to Sickle Cell Disease
Related terms Anemia, Sickle Cell
Enrollment 100 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov